What is the Allergy Follow-up for Children After Anaphylactic Reaction? AFCAR : Allergy Follow-up for Children After Anaphylactic Reaction

Anaphylaxis is an allergic reaction potentially fatal. The treatment is based on injection of epinephrin as soon as possible. Guidelines by the World Allergic Organisation highlight the importance of medical follow-up. This follow-up consists of an allergy consultation, the prescription and demonstration of epinephrin auto-injector and the implementation of specific measures in schools. There is no study about the recurrence of anaphylactic reaction outside the hospital.

The purpose of this study is to evaluate the allergy follow-up of children after anaphylactic reaction. The secondary objective is to evaluate the use of medical advice in case of recurrence of anaphylactic reaction.

Investigators will use a phone call questionnaire for parents of children who underwent an anaphylactic reaction between the 1st July 2014 and the 31st June 2016 treated in the Paediatric Emergency Department in Femme-Mère-Enfant Hospital in Lyon in France. 179 children could be included in the study.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anaphylaxis Allergic Reaction Hypersensitivity Hypersensitivity, Immediate Immune System Diseases

Age range

Up to 18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Paediatric Emergency Department in Femme-Mère-Enfant Hospital

Bron, 69677, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age from 0 to 17
Anaphylactic reaction meeting the criteria of Sampson et al. treated in Paediatric Emergency Department of Femme-Mère-Enfant Hospital in Lyon in France
Anaphylactic reaction treated between the 1st July 2014 and the 31st June 2016

Exclusion criteria

No agreement from patient or parents to participate in the study

Treatment and study plan

Phone call questionnaire

Other

Questionnaire for parents of subject about :

the frequency of consultations with an allergist
the information of the general practitioner or pediatrician
the prescription of epinephrin auto-injector
the frequency of renewal of epinephrin auto-injector
the specialty of doctor who prescribed the renewal
the implementation of specific measures in schools
the frequency of renewal of specific measures in schools
the number of recurrence of anaphylactic reaction
the use of medical advice in case of recurrence of anaphylactic reaction

Primary outcomes

Allergy follow-up

Time frame: About 15 minutes
Allergy follow-up evaluation with :
- the frequency of consultations with an allergist
- the information of the general practitioner or pediatrician
- the prescription of epinephrin auto-injector
- the frequency of renewal of epinephrin auto-injector
- the specialty of doctor who prescribed the renewal
- the implementation of specific measures in schools
- the frequency of renewal of specific measures in schools
- the number of recurrence of anaphylactic reaction
- the use of medical advice in case of recurrence of anaphylactic reaction

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Acronym: SAPRA

Important dates

Study start: 2019
Primary completion: 2019
Study completion: 2019
First posted: May 8, 2019
Registry last updated: Oct 9, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed